Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 3/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.41 |
| ▸ | ADAMTS4 | O75173 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 6/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.37 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.37 |
| ▸ | MMP7 | P09237 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 2/20 | 0.36 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14025844 | 0.85 | MMP1 (0.54) | MMP1ADAM17MMP13MMP9ADAM10 | |
| SCHEMBL4915080 | 0.85 | MMP1 (0.54) | MMP1ADAM17MMP13MMP9ADAM10 | |
| SCHEMBL14045868 | 0.83 | SLC1A3 (0.60) | SLC1A3SLC1A2SLC1A1ADAM17ADAMTS4 | |
| SCHEMBL14045735 | 0.76 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1MMP1ADAM17 | |
| SCHEMBL14045830 | 0.74 | SLC1A3 (0.57) | SLC1A3SLC1A2SLC1A1MMP1ADAM17 | |
| SCHEMBL14045736 | 0.73 | ADAMTS4 (0.64) | SLC1A3SLC1A2SLC1A1MMP1ADAMTS4 | |
| SCHEMBL20998631 | 0.72 | ALDH1A1 (0.50) | MMP1ALDH1A1LOXL2MMP13MMP9 | |
| SCHEMBL11681712 | 0.72 | LOXL2 (0.50) | ALDH1A1LOXL2LMNASMN1; SMN2 | |
| SCHEMBL4928565 | 0.70 | MMP2 (0.45) | ALDH1A1LOXL2MMP13MMP9MMP8 | |
| SCHEMBL25517468 | 0.70 | ALDH1A1 (0.50) | ALDH1A1LOXL2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | AOC2, AOC3, AOC1 | SLC1A3 217/4885SLC1A2 434/4885SLC1A1 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.